Childhood Adversity, Inflammatory Reactivity and Persistent Pain

Chronic Pain Clinical Trial

— CAIR  

Official title:

The Roles of Childhood Adversity and Inflammatory Reactivity in Promoting Pain and Fatigue After Provocation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06127693
• Other study ID #: HREC REF 560/2021
• Status: Completed
• Start date: June 21, 2022
• Est. completion date: September 20, 2023

Study information

• Verified date: November 2023
• Source: University of Cape Town
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observational study is to investigate how adverse experiences during childhood are linked to people experiencing persistent pain and fatigue in adulthood. The questions the investigators aim to answer are: 1. Does participant-reported childhood adversity predict levels of IL-6 and TNF-α after in vitro provocation of whole blood using endotoxin? 2. Do levels of IL-6 and TNF-α after in vitro immune provocation using endotoxin predict vulnerability to persistent pain and fatigue after in vivo immune provocation (tetravalent influenza vaccine)? 3. Do levels of IL-6 and TNF-α after in vitro immune provocation using endotoxin predict vulnerability to persistent pain and fatigue after in vivo neural provocation? For this study, the investigators will recruit and enrol 96 healthy human adults (18 - 65 years old) with a range of adverse experiences during childhood. Participants will attend 2 study sessions during which the investigators will take a sample of blood, assess pressure pain threshold before and after cold water immersion, assess heart rate variability, and assess the surface area of secondary skin hypersensitivity after electrical stimulation. At the end of the first session, participants will receive the influenza vaccination.

Description:

Background Adverse experiences during childhood (childhood adversity) are associated with an increased risk of persistent pain and fatigue in adulthood. While the physiological relationships that link childhood adversity, persistent pain, and fatigue are unclear, all three factors are each associated with heightened innate immune and neural responses in adulthood. As such, neuroimmune interactions could underlie the relationship between childhood adversity, persistent pain, and fatigue, although the balance between the immune and neural influences likely varies across individuals.The investigators hypothesise that childhood adversity influences persistent pain and fatigue by priming: 1) immune, 2) neural, or 3) both systems, within an individual. Although previous studies have examined either immune or neural processes representing vulnerability to persistent pain and fatigue, the investigators are not aware of any study that has investigated both systems in the same cohort. Methods 96 healthy adult humans with a range of childhood adversity history will undergo psychophysical testing before and after in vivo neural provocation (high frequency electrical stimulation) and, separately, immune provocation (influenza vaccine). Study proxies for vulnerability to persistent pain are surface area of secondary skin hypersensitivity induced by neural provocation and change in conditioned pain modulation after immune provocation; the proxy for vulnerability to fatigue is heart rate variability 24h after immune provocation. Immune responsiveness is represented by IL-6 and TNF-α levels in supernatant after in vitro lipopolysaccharide provocation of whole blood. The investigators hypothesise that levels of IL-6 and TNF-α after in vitro immune provocation will be positively associated with the area of secondary skin hypersensitivity after in vivo neural provocation, and negatively associated with conditioned pain modulation after in vivo immune provocation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 101
• Est. completion date: September 20, 2023
• Est. primary completion date: September 20, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Between the ages of 18 and 65 years old.

Exclusion Criteria:

• Incompetence to consent and participate, e.g. acute psychosis or high suicide risk.
• Pregnancy,
• Electrical implants (e.g. pace-maker),
• Metal implants in the forearm,
• Tattoos on the forearm,
• Any visible injury or open wounds in the forearm,
• Known history of allergic reactions to vaccines,
• Has received the current season's influenza vaccine,
• Chronic pain (pain on most days for the past 3 months),
• Diabetes Mellitus,
• Peripheral vascular disease,
• Sensory impairment in the forearm, shoulder and lower back,
• Use of medication that could later skin sensitivity (e.g. analgesic medication, immune modulators, topical medical creams),
• Cardiovascular disorders,
• Medication that alters immune function (e.g. NSAIDs, steroids),
• Smoking habit,
• Febrile illness in the preceding 4 weeks.

Related Conditions & MeSH terms

• Adverse Childhood Experiences
• Central Sensitisation
• Chronic Pain
• Immune Response

Intervention

Drug:
• Tetravalent Influenza Vaccine
All participants will receive the tetravalent influenza vaccine

Behavioral:
• High-frequency electrical stimulation
All participants will receive High-frequency electrical stimulation

Locations

Country	Name	City	State
South Africa	University of Cape Town	Cape Town	Western Cape

Sponsors (1)

Lead Sponsor	Collaborator
University of Cape Town

Country where clinical trial is conducted

South Africa, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Childhood Trauma Questionnaire-Short form	The Childhood Trauma Questionnaire-Short form uses 28 statements to probe five domains: emotional abuse, physical abuse, sexual abuse, emotional neglect, and physical neglect. Participants rate the extent to which each of the 28 possible situations was true during their childhood and adolescence, on a 5-point Likert scale ranging from "never true" to "very often true". The total score is computed by summing scores across forward- and reverse-coded items and a separate denial score that is obtained using three of the items. A higher score indicates more childhood adversities (i.e. worse outcome). The investigators will use the total score on the Childhood Trauma Questionnaire-Short to recruit specifically for a varied range in childhood adversity history and enrol participants into three similarly sized groups: 1) minimal childhood adversity (control) (score 25-36), 2) moderate childhood adversity (score 37-67), and 3) severe childhood adversity (score > 67).	Baseline
Primary	Provoked inflammatory response	Mean z-scores of IL-6 and TNF-alpha levels	Baseline
Primary	Secondary hypersensitivity (surface area)	Surface area of secondary hypersensitivity induced by high-frequency electrical stimulation	30 minutes, 45 minutes and 60 minutes after the high-frequency electrical stimulation (neural provocation)
Primary	Conditioned pain modulation	Change in pressure pain threshold (test stimulus) after cold water immersion (conditioning stimulus)	Baseline and 24 hours after the influenza vaccine (immune provocation).
Primary	Temporal summation	Mechanical stimuli will be provided from a 256mN von Frey Filament. Participants will provide ratings to mechanical stimuli using the Sensation and Pain Rating Scale. The Sensation and Pain Rating Scale has a 'non-painful' range, on the left of the scale, ranging from -50 - "no sensation" to 0 - "the exact point at which what you feel transitions to pain". The 'painful' range, on the right of the scale, ranges from 0 to +50 - "most intense pain you can imagine". A lower score means less intense sensation/pain (i.e. better outcome) and a higher score means more intense sensation/pain (i.e. worse outcome).	Baseline and 24 hours after the influenza vaccine (immune provocation).
Secondary	Heart rate variability	Using 3-lead ECG and Biopac System	Baseline, 40 minutes after the high-frequency electrical stimulation (neural provocation), and 24 hours after the influenza vaccine (immune provocation).
Secondary	N-back test	Assessing working memory	Baseline and 24 hours after the influenza vaccine (immune provocation).
Secondary	6-minute walk test	Assessing physical exertion and recovery	Baseline and 24 hours after the influenza vaccine (immune provocation).
Secondary	Secondary hypersensitivity (magnitude)	Change in ratings on the Sensation and Pain Rating Scale to punctate mechanical stimulation. The Sensation and Pain Rating Scale has a 'non-painful' range, on the left of the scale, ranging from -50 - "no sensation" to 0 - "the exact point at which what you feel transitions to pain". The 'painful' range, on the right of the scale, ranges from 0 to +50 - "most intense pain you can imagine". A lower score means less intense sensation/pain (i.e. better outcome) and a higher score means more intense sensation/pain (i.e. worse outcome).	Baseline, and 35 minutes, 50 minutes and 65 minutes after the high-frequency electrical stimulation (neural provocation).
Secondary	Static and dynamic light touch, and single electrical stimulation	Change in ratings on the Sensation and Pain Rating Scale to punctate mechanical stimulation. The Sensation and Pain Rating Scale has a 'non-painful' range, on the left of the scale, ranging from -50 - "no sensation" to 0 - "the exact point at which what you feel transitions to pain". The 'painful' range, on the right of the scale, ranges from 0 to +50 - "most intense pain you can imagine". A lower score means less intense sensation/pain (i.e. better outcome) and a higher score means more intense sensation/pain (i.e. worse outcome).	Baseline, and 35 minutes, 50 minutes and 65 minutes after the high-frequency electrical stimulation (neural provocation)